Incorporating patient values into health outcomes is known as Patient Value Mapping (PVM). CaPPRe are experts in PVM and work closely with industry, academia and government to encourage patient involvement in healthcare decision making.

CaPPRe provides pharmaceutical and medical device companies with professional guidance on tailored research solutions to assist with market access and reimbursement strategies in both local and global markets. This includes a broad mix of research offerings including patient value mapping (PVM), patient experience journeys, patient and clinician preference studies and payer willingness to pay (WTP) studies. CaPPRe is committed to helping support better access to treatments by understanding what is valued by patients, clinicians, payers and policy makers in a rapidly transforming landscape.

Our healthcare team brings a world of multidisciplinary and therapeutic area experience to its healthcare projects. Our areas of expertise include:

• Cardiovascular disease
• Dermatology
• Endocrinology
• Haematology
• Oncology
• Mental Health
• Rare Diseases
• Renal Disease
• Respiratory Disease
• Rheumatology
• Vaccines

Healthcare clients CaPPRe have worked with:

• Amgen
• AstraZeneca
• Celgene
• Janssen
• Rare Cancers Australia
• Roche
• Sanofi
• Shire

Patient advocacy groups/Non-profit organisations we have partnered with:

• Myeloma UK
• Myeloma Australia
• Prostate Cancer Foundation Australia
• SANE Australia
• Leukaemia Foundation

Countries we have conducted research in:

• Australia
• Canada
• France
• Hong Kong
• Italy
• Japan
• New Zealand
• Singapore
• Taiwan
• Thailand
• UK